The effect of hesperidin and quercetin on oxidative stress, NF-κB and SIRT1 levels in a STZ-induced experimental diabetes model

Biomedicine and Pharmacotherapy

Volumn 90, Issue , 2017, Pages 500-508

  Iskender, Hatice ^a   Dokumacioglu, Eda ^a   Sen, Tugba Mazlum ^b   Ince, Imran ^b   Kanbay, Yalcin ^a   Saral, Sinan ^c  

^a ARTVIN CORUH UNIVERSITY   (Turkey)

^b KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^c RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

Author keywords

Diabetes; Hesperidin; NF B; Oxidative stress; Quercetin; Sirtuin 1

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CATALASE; CREATININE; GLUCOSE; HESPERIDIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; QUERCETIN; SIRTUIN 1; SUPEROXIDE DISMUTASE; UREA; ANTIOXIDANT; BIOLOGICAL MARKER; SIRT1 PROTEIN, RAT; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHEMICAL COMPOSITION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; KIDNEY INJURY; KIDNEY TISSUE; LIVER INJURY; LIVER TISSUE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UREA BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; ANIMAL; CHEMICALLY INDUCED; DIABETIC NEPHROPATHY; DISEASE MODEL; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; KIDNEY; LIVER; MALE; METABOLISM; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BIOMARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; HESPERIDIN; KIDNEY; LIVER; MALE; NF-KAPPA B; OXIDATIVE STRESS; QUERCETIN; RATS; RATS, WISTAR; SIRTUIN 1; STREPTOZOCIN;

EID: 85017146018     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.03.102     Document Type: Article

References (79)

1. [1] Turkmen, K., Karagoz, A., Kucuk, A., Sirtuins as novel players in the pathogenesis of diabetes mellitus. World J. Diabetes 5 (2014), 894–900.
2. [2] Skyler, J.S., Oddo, C., Diabetes trends in the USA. Diabetes Metab. Res. Rev. 3 (2002), 21–26.
3. [3] Altan, N., Dincel, A.C., Koca, C., Diabetes mellitus and oxidative stress. Turk. J. Biochem. 31 (2006), 51–56.
4. [4] Vincent, A.M., Russell, J.W., Low, P., Feldman, E.L., Oxidative stress in the pathogenesis diabetic neuropathy. Endocr. Rev. 25 (2004), 612–628.
5. [5] Memisogullari, R., Taysi, S., Bakan, E., Capoglu, I., Antioxidant status and lipid peroxidation in type ii diabetes mellitus. Cell Biochem. Funct. 21 (2003), 291–296.
6. [6] Valko, M., Leibfritz, D., Moncol, J., Cronin, M.T.D., Mazur, M., Telser, J., Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39 (2007), 44–84.
7. [7] Thomas, B., Rao, A., Prasad, B.R., Kumari, S., Serum levels of antioxidants and superoxide dismutase in periodontitis patients with diabetes type 2. J. Indian Soc. Periodontol. 18 (2014), 451–455.
8. [8] Baldwin, A.S. Jr., Series introduction: the transcription factor NF-kappaB and human disease. J. Clin. Invest. 107 (2001), 3–6.
9. [9] Gilmore, T.D., The Re1/NF-kappa B/I kappa B signal transduction pathway and cancer. Cancer Treat. Res. 115 (2003), 241–265.
10. [10] Melloul, D., Role of NFκB in β-cell death. Biochem. Soc. Trans. 36 (2008), 334–339.
11. [11] Ghosh, S., Hayden, M.S., Celebrating 25 years of NF-κB research. Immunol. Rev. 246 (2012), 5–13.
12. [12] Kaeberlein, M., Kirkland, K.T., Fields, S., Kennedy, B.K., Sir2-independent life span extension by calorie restriction in yeast. PLoS Biol., 2, 2004, E296.
13. [13] Nogueiras, R., Habegger, K.M., Chaudhary, N., Finan, B., Banks, A.S., Dietrich, M.O., Horvath, T.L., Sinclair, D.A., Pfluger, P.T., Tschöp, M.H., Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. Physiol. Rev. 92 (2012), 1479–1514.
14. [14] Baur, J.A., Biochemical effects of SIRT1 activators. Biochim. Biophys. Acta 1804 (2010), 1626–1634.
15. [15] Dong, Y., Guo, T., Traurig, M., Mason, C.C., Kobes, S., Perez, J., Knowler, W.C., Bogardus, C., Hanson, R.L., Baier, L.J., SIRT1 is associated with a decrease in acute insulin secretion and a sex specific increase in risk for type 2 diabetes in Pima Indians. Mol. Genet. Metab. 104 (2011), 661–665.
16. [16] Gillum, M.P., Erion, D.M., Shulman, G.I., Sirtuin-1 regulation of mammalian metabolism. Trends Mol. Med. 17 (2011), 8–13.
17. [17] Vinayagam, R., Xu, B., Antidiabetic properties of dietary flavonoids: a cellular mechanism review. Nutr. Metab. (Lond.), 12, 2015, 60.
18. [18] Adewole, S.O., Caxton-Martins, E.A., Ojewole, J.A.O., Protective effect of quercetin on the morphology of pancreatic beta-cells of streptozotocin-treated diabetic rats. Afr. J. Tradit. Complement. Altern. Med. 4 (2007), 64–74.
19. [19] Erlund, I., Review of the flavonoids quercetin, Hesperetin, and Naringenin Dietary sources, bioactivities, bioavailability, and epidemiology. Nutr. Res. 24 (2004), 851–874.
20. [20] Kakadiya, J., Mulani, H., Shah, N., Protective effect of hesperidin on cardiovascular complication in experimentally induced myocardial infarction in diabetes in rats. J. Basic Clin. Pharm. 1 (2010), 85–91.
21. [21] Demir, E.A., Gergerlioglu, H.S., Oz, M.M., Antidepressant-like effects of quercetin in diabetic rats are independent of hypothalamic–pituitary–adrenal axis. Acta Neuropsychiatr. 28 (2016), 23–30.
22. [22] Ramos-Lobo, A.M., Buonfiglio, D.C., Cipolla-Neto, J., Streptozotocin-induced diabetes disrupts the body temperature daily rhythm in rats. Diabetol. Metab. Syndr., 7, 2015, 39.
23. [23] Dewanjee, S., Das, A.K., Sahu, R., Gangopadhyay, M., Antidiabetic activity of Diospyros peregrina fruit: effect on hyperglycemia, hyperlipidemia and augmented oxidative stress in experimental type 2 diabetes. Food Chem. Toxicol. 47 (2009), 2679–2685.
24. [24] Ohkawa, H., Oshishi, N., Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbuturic acid reaction. Anal. Biochem. 95 (1979), 351–358.
25. [25] McCord, J.M., Fridovich, L., Superoxide dismutase. An enzymatic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244 (1969), 6049–6055.
26. [26] Beutler, E., Glutathion. Beutler, E., (eds.) Red Cell Metabolism: A Manual of Biochemical Methods, 1975, Grune and Stratton, New York, 105–107.
27. [27] Dabla, P.K., Renal function in diabetic nephropathy. World J. Diabetes 1 (2010), 48–56.
28. [28] Lu, Q., Yın, X.X., Wang, J.Y., Gao, Y.Y., Pan, Y.M., Effects of Ginkgo Biloba on prevention of development of experimental diabetic nephropathy in rats. Acta Pharmacol. Sin. 28 (2007), 818–828.
29. [29] Choi, Y.E., Ahn, S.K., Lee, W.T., Lee, J.E., Park, S.H., Yoon, B.B., Park, K.A.K.A., Soybeans ameliolarate diabetic nephropathy in rats. Evid. Based Complement. Alternat. Med. 7 (2010), 433–440.
30. [30] Tavares de Almeida, D.A., Braga, C.P., Barbosa Novelli, E.L., Henrique Fernandes, A.A., Evaluation of lipid profile and oxidative stress in STZ-induced rats treated with antioxidant vitamin. Braz. Arch. Biol. Technol. 55 (2012), 527–536.
31. [31] Levinthal, G.N., Tavill, A.S., Liver disease and diabetes mellitus. Clin. Diabet. 17 (1999), 245–250.
32. [32] Bhargavi, G., Josthna, P., Naidu, C.V., Changes in serum biochemical parameters and lipid profile in normal and STZ-induced diabetic rats with the administration of ethanolic extract of polyalthia cerasoides stem bark. Int. Res. J. Pharm. 6 (2015), 153–156.
33. [33] Gomes, I.B., Porto, M.L., Santos, M.C., Campagnaro, B.P., Gava, A.L., Meyrelles, S.S., Pereira, T.M., Vasquez, E.C., The protective effects of oral low-dose quercetin on diabetic nephropathy in hypercholesterolemic mice. Front. Physiol., 6, 2015, 247.
34. [34] Abo-Salem, O.M., El-Edel, R.H., Harisa, G.E., El-Halawany, N., Ghonaim, M.M., Experimental diabetic nephropathy can be prevented by propolis: effect on metabolic disturbances and renal oxidative parameters. Pak. J. Pharm. Sci. 22 (2009), 205–210.
35. [35] Elbe, H., Vardi, N., Esrefoglu, M., Ates, B., Yologlu, S., Taskapan, C., Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats. Hum. Exp. Toxicol. 34 (2015), 100–113.
36. [36] Jain, D.P., Somani, R.S., Hesperidin ameliorates streptozotocin and high fat diet induced diabetic nephropathy in rats. J. Exp. Integr. Med. 4 (2014), 261–267.
37. [37] Tirkey, N., Pilkhwal, S., Kuhad, A., Chopra, K., Hesperidin, a citrus bioflavonoid, decreases the oxidative stress produced by carbon tetrachloride in rat liver and kidney. BMC Pharmacol. 5 (2005), 1–8.
38. [38] Zahran, F.M., Al-Hussaini, A.S., Abou-Mesalam, A.I., Hepatoprotective effect of cinnamaldehyde and hesperidin mixture on induced type-1 diabetic rats. Int. J. Biol. Pharm. Res. 7 (2016), 74–82.
39. [39] Altan, N., Dincel, A.S., Koca, C., Diabetes mellitus and oxidative stress. Turk. J. Biochem. 31 (2006), 51–56.
40. [40] Coskun, O., Kanter, M., Korkmaz, A., Oter, S., Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and β cell damage in rat pancreas. Pharmacol. Res. 51 (2005), 117–123.
41. [41] Carlioglu, A., Akdeniz, D.D., Alkan, R., Uz, E., Haltas, H., Turgut, F., Uysal, S., The effect of zofenopril on pancreas, kidney and liver of diabetic rats. Turk. Neph. Dial. Transpl. 23 (2014), 118–124.
42. [42] Alam, M., Meerza, D., Naseem, I., Protective effect of quercetin on hyperglycemia, oxidative stress and DNA damage in alloxan induced type 2 diabetic mice. Life Sci. 109 (2014), 8–14.
43. [43] Akaya, H., Çelik, S., Oksidan and antioksidant situation before and after diabets in rat. F.U. J. Vet. Healthy Sci. 24 (2010), 5–10.
44. [44] McAnuff, M.A., Omoruyi, F.O., Morrison, E.Y., Asemota, H.N., Hepatic function enzymes and lipid peroxidation in streptozotocin induced diabetic rats fed bitter yam (Dioscorea polygonoides) steroidal sapogenin extract. Diabetol. Croat. 32 (2003), 17–23.
45. [45] Obrosova, I.G., Fathallah, L., Lıu, E., Nourooz-Zadeh, J., Early oxidative stress in the diabetic kidney: effect of DL-alfa-lipoic acid. Free Radic. Biol. Med. 34 (2003), 186–195.
46. [46] Maritim, A.C., Sanders, R.A., Watkins, J.B., Diabetes, oxidative stress and antioxidants: a review. J. Biochem. Mol. Toxicol. 17 (2003), 24–38.
47. [47] Maciel, R.M., Costa, M.M., Martins, D.B.D.B., et al. Antioxidant and anti-inflammatory effects of quercetin in functional and morphological alterations in streptozotocin-induced diabetic rats. Res. Vet. Sci. 95 (2013), 389–397.
48. [48] Vessal, M., Hemmati, M., Vasie, M., Antidiabetic effects of quercetin in streptozocin induced diabetic rats. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 135 (2003), 357–364.
49. [49] Moskaug, J.Q., Carlsen, H., Myhrstad, M., Blomhoff, R., Molecular imaging of the biological effects of quercetin and quercetin-rich foods. Mech. Ageing Dev. 125 (2004), 315–324.
50. [50] Edremitlioğlu, M., Antic, M.F., Sayin, D.B., Korkut, O., Kısa, U., Quercetin, a powerful antioksidant bioflavonoid, attenuates renal dysfunction in long-term experimental diabetes mellitus. Marmara Med. J. 24 (2011), 88–99.
51. [51] Edremitlioğlu, M., Andiç, M.F., Korkut, O.O., Quercetin, a powerful antioksidant bioflavonoid, prevents oxidative damage in different tissues of long-term diabetic rats. Balkan Med. J. 29 (2012), 49–55.
52. [52] Molina, M.F., Sanchez-Reus, I., Iglesias, I., Benedi, J.J., Quercetin, a flavonoid antioxidant, prevents and protects against ethanol-induced oxidative stress in mouse liver. Biol. Pharm. Bull. 26 (2003), 1398–1402.
53. [53] Phachonpai, W., Wattanathorn, J., Muchimapura, S.S., Tong-Un, T., Preechagoon, D., Neuroprotective effect of quercetin encapsulated liposomes: a novel therapeutic strategy against alzheimer's disease. Am. J. Appl. Sci. 7 (2010), 480–485.
54. [54] Sriraksa, N., Wattanathorn, J., Muchimapura, S.S., Tiamkao, S., Brown, K., Chaisiwamongkol, K., Cognitive-enhancing effect of quercetin in a ratmodel of parkinson's disease induced by 6-hydroxydopamine. Evid. Based Complement. Alternat. Med., 2012, 2012, 823206.
55. [55] Mahmoud, A.M., Ashour, M.B., Abdel-Moneim, A., Ahmed, O.M., Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats. J. Diabetes Complications 26 (2012), 483–490.
56. [56] Çetin, A., Çiftçi, O., Otlu, A., Protective effect of hesperidin on oxidative and histological liver damage following carbon tetrachloride administration in Wistar rats. Arch. Med. Sci. 12 (2016), 486–493.
57. [57] Kowluru, R.A., Tang, J., Kern, T.S., Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 50 (2001), 1938–1942.
58. [58] Montilla, P., Barcos, M., Munoz, M.C., Bujalance, I., Munoz-Castaneda, J.R., Tunez, I., Red wine prevents brain oxidative stress and nephropathy in streptozotocin-induced diabetic rats. J. Biochem. Mol. Biol. 38 (2005), 539–544.
59. [59] Craven, P.A., Studer, R.K., Felder, J., Phillips, S., DeRubertis, F.R., Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells. Diabetes 46 (1997), 671–681.
60. [60] Forbes, J.M., Cooper, M.E., Thallas, V., Burns, W.C., Thomas, M.C., Brammar, G.C., Lee, F., Grant, S.L., Burrell, L.M., Jerums, G., Osicka, T.M., Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes 51 (2002), 3274–3282.
61. [61] Iwasaki, Y., Kambayashi, M., Asai, M., Yoshida, M., Nigawara, T., Hashimoto, K., High glucose alone, as well as in combination with proinflammatory cytokines, stimulates nuclear factor kappa-B-mediated transcription in hepatocytes in vitro. J. Diabetes Complications 21 (2007), 56–62.
62. [62] Dias, A.S., Porawski, M., Alonso, M., Marroni, N., Collado, P.S., González-Gallego, J., Quercetin decreases oxidative stress, NF-kappaB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. J. Nutr. 135 (2005), 2299–2304.
63. [63] Mohamed, A.K., Bierhaus, A., Schiekofer, S., Tritschler, H., Ziegler, R., Nawroth, P.P., The role of oxidative stress and NF-kappaB activation in late diabetic complications. Biofactors 10 (1999), 157–167.
64. [64] Locke, M., Anderson, J., NF-κB activation in organs from STZ-treated rats. Appl. Physiol. Nutr. Metab., 36, 2011, 121.
65. [65] Da Ros, R., Assaloni, R., Ceriello, A.A., The preventive anti-oxidant action of thiazolidinediones: a new therapeutic prospect in diabetes and insulin resistance. Diabet. Med. 21 (2004), 1249–1252.
66. [66] Garcia-Mediavilla, V., Crespo, I., Collado, P., Esteller, A., Sanchez-Campos, S.S., Tuñón, M.J., González-Gallego, J., The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and relative C-protein, and down-regulation of the nuclear factor-kappaB pathway in Chang liver cells. Eur. J. Pharmacol. 557 (2007), 221–229.
67. [67] Ruiz, P.A., Braune, A., Hölzlwimmer, G., Quintanilla-Fend, L., Haller, D., Quercetin inhibits TNF-induced NF-κB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells. J. Nutr. 137 (2007), 1208–1215.
68. [68] Granado-Serrano, A., Martin, M., Bravo, L., Goya, L., Ramos, S., Quercetin modulates NF-κB and AP-1/JNK pathways to induce cell death in human hepatoma cells. Nutr. Cancer. 62 (2010), 390–401.
69. [69] El-Shafey, M.M., Abd-Ellah, M.F., Hesperidin improves lipid profile and attenuates oxidative stress in hypercholesterolemic rats. Int. J. Pharm. Sci. 3 (2014), 554–559.
70. [70] Shi, X., Liao, S., Mi, H., Guo, C., Qi, D., Li, F., Zhang, C., Yang, Z., Hesperidin prevents retinal and plasma abnormalities in streptozotocin-induced diabetic rats. Molecules 17 (2012), 12868–12881.
71. [71] Ahmad, S.T., Arjumand, W., Nafees, S., Seth, A., Ali, N., Rashid, S., Sultan, S., Hesperidin alleviates acetaminophen induced toxicity in wistar rats by abrogation of oxidative stress, apoptosis and inflammation. Toxicol. Lett. 208 (2012), 149–161.
72. [72] Kalle, A.M., Mallika, A., Badiger, J., Alinakhi, Talukdar, P., Sachchidanand, Inhibition of SIRT1 by a small molecule induces apoptosis in breast cancer cells. Biochem. Biophys. Res. Commun. 401 (2010), 13–19.
73. [73] Jung, Y.J., Lee, J.E., Lee, A.S., Kang, K.P., Lee, S., Park, S.K., Lee, S.Y., Han, M.K., Kim, D.H., Kim, W., SIRT1 overexpression decreases cisplatin-induced acetylation of NF-κB p65 subunit and cytotoxicity in renal proximal tubule cells. Biochem. Biophys. Res. Commun. 419 (2012), 206–210.
74. [74] Li, C., Cai, F., Yang, Y., Zhao, X., Wang, C., Li, J., Jia, Y., Tang, J., Liu, Q., Tetrahydroxystilbene glucoside ameliorates diabetic nephropathy in rats: involvement of SIRT1 and TGF-β1 pathway. Eur. J. Pharmacol. 649 (2010), 382–389.
75. [75] Orimo, M., Minamino, T., Miyauchi, H., Tateno, K., Okada, S., Moriya, J., Komuro, I., Protective role of SIRT1 in diabetic vascular dysfunction. Arterioscler. Thromb. Vasc. Biol. 29 (2009), 889–894.
76. [76] Peredo-Escárcega, A.E., Guarner-Lans, V., Pérez-Torres, I., Ortega-Ocampo, S., Carreón-Torres, E., Castrejón-Tellez, V., Díaz-Díaz, E., Rubio-Ruiz, M.E., The combination of resveratrol and quercetin attenuates metabolic syndrome in rats by modifying the serum fatty acid composition and by upregulating SIRT 1 and SIRT 2 expression in white adipose tissue. Evid. Based Complement. Alternat. Med., 2015, 2015, 474032.
77. [77] Allard, J.S., Perez, E., Zou, S., de Cabo, R., Dietary activators of Sirt1. Mol. Cell. Endocrinol. 299 (2009), 58–63.
78. [78] Okamoto, T., Safety of quercetin for clinical application. Int. J. Mol. Med. 16 (2005), 275–278 (Review).
79. [79] Egert, S., Wolffram, S., Bosy-Westphal, A., Boesch-Saadatmandi, C., Wagner, A.E., Frank, J., Rimbach, G., Mueller, M.J., Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J. Nutr. 138 (2008), 1615–1621.